LAVAL, QC, Sept. 24, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce new customer relationships for which the Company is expected to provide hemp-derived finished-form products and bulk extracts processed at Neptune's U.S. extraction facility. The company is also in discussion with se

A paper entitled, "Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I Study", has been published summarizing the data from RepliCel's clinical trial of RCS-01 VANCOUVER, Sept. 24, 2019 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the "Company"), a

NEW YORK, Sept. 24, 2019 /PRNewswire/ -- The rise in illnesses caused by our behaviours and the social determinants of health threatens to suffocate budgets in both wealthy and poor countries, while suppressing the power of modern medicine to improve lives. PwC's new report "Action required: The urgency of addressing social determinants of health" outlines wh

SAN FRANCISCO, Sept. 24, 2019 /PRNewswire/ -- Alexander Lorestani, CEO and co-founder of conscious biodesign company Geltor, will present to attendees of the SynBioBeta conference in San Francisco on October 2, 2019. Lorestani will give a featured talk on designing beauty produc

NEWPORT BEACH, Calif., Sept. 24, 2019 /PRNewswire/ -- Titan HST received the Best Technology Innovation in Software award Thursday evening, September 12, at the 2019 High Tech Awards (HTA), hosted by OCTANe at the Balboa Bay Resort in Newport Beach. Now in its' 26th year, the program recognizes individ

WASHINGTON, Sept. 24, 2019 /PRNewswire/ -- U.S. News & World Report, the global authority in hospital rankings, will convene industry leaders from arou

REDWOOD SHORES, Calif., Sept. 24, 2019 /PRNewswire/ -- Clinical trials are the foundation for getting needed drug and medical treatments to market. However, a new global survey found that disjointed technologies and undue complexity in sharing information and training is stalling outcomes.

BERLIN and BOSTON, Sept. 24, 2019 /PRNewswire/ -- Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases. The joint lab will host scientists from all three parties a

STOCKHOLM, Sept. 24, 2019 /PRNewswire/ -- A new cell imaging technology guide has been launched by leading independent science publisher SelectScience&

STOCKHOLM, Sept. 24, 2019 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that all stock options 1) held by management team members under the Employee Stock Option Program 2012/2019 with associated warrants have been exercised. Gains from stock option programs are taxed as ordinary income in Sweden and t